EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Influence of canstatin on fibroblast-driven hypervascularisation in rheumatoid arthritis

Corinna Heck, Birgit Zimmermann-Geller, Sophie Haun, Frederik Lötfering, Paula Welbrink, Daria Kürsammer, Klaus W Frommer, Mona Arnold-Gräf, Adelheid Korb-Pap, Anna Knothe, Nils Schulz, Stefan Simianer und 10 weitere

Annals of the Rheumatic Diseases · 2025

DOI: 10.1016/j.ard.2025.05.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2025. Verfasst von Corinna Heck und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Justus Liebig University Giessen, Campus Kerckhoff, Bad Nauheim, Germany. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Synovial Membrane, Fibroblasts, Neovascularization, Pathologic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pickenpack Foundation, Kerckhoff-Foundation, BMBF Bonn.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Hypervascularisation is a dominant feature of the inflamed synovium in rheumatoid arthritis (RA). As RA synovial fibroblasts (RASFs) are key cells of synovial pathophysiology and are located adjacent to the aberrant endothelial cells (ECs), we hypothesised that this interaction might be responsible for the pathological hypervascularisation. METHODS: In the severe combined immunodeficiency (SCID) mouse model for RA, RASF-mediated helix-like vessel (HLV) formation was described and modulated by canstatin, an antiangiogenic collagen IV fragment that blocks the angiopoietin (ANGPT)/Tie2 pathway in EC. ANGPT2/CD31 and CXCL2 immunofluorescence on implants and human synovium was performed. RASF were stimulated with interleukin (IL)-1β once or repetitively and immunoassays, real-time polymerase chain reaction and RNA sequencing were performed. Two-dimensional (2D) tube formation and 3-dimensional spheroid-based assays using human umbilical vein ECs and fluorescent-stained RASF with/without canstatin, IL-11 and CXCL2 were evaluated. RESULTS: In SCID mice, RASF-specific HLV formation started early and increased until day 30. The number of HLV was significantly reduced by canstatin. Compared to osteoarthritis synovium, ANGPT2 was significantly upregulated in RA vessels. Repetitive RASF stimulation significantly decreased IL-6, IL-11 and CXCL-2 compared to RASF stimulated once with IL-1β. When RASF was stimulated once, CXCL2 and IL-11 were significantly reduced along with 2D tube formation, while repetitive stimulation significantly attenuated hypervascularisation. RNAseq revealed underlying pathways leading to altered tube formation. CONCLUSIONS: We showed that RASF affect vascularisation in vitro and in vivo. The results support the idea that canstatin is able to alter the RASF pathological HLV formation. In the SCID mouse model, this was regulated on a molecular level mediated by ANGPT2 in a vascular endothelial growth factor A-independent manner, contributing significantly to one of the central aspects of RA pathophysiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidSynovial MembraneFibroblastsNeovascularization, PathologicAnimalsHumansMice, SCIDMiceDisease Models, AnimalHuman Umbilical Vein Endothelial CellsAngiopoietin-2Interleukin-1beta

Substanzen

Angiopoietin-2Interleukin-1beta

Autor:innen und Institutionen

  • Department of Rheumatology and Clinical Immunology, Justus Liebig University Giessen, Campus Kerckhoff, Bad Nauheim, Germany.
  • Institute of Musculoskeletal Medicine, University Hospital Muenster, Muenster, Germany.
  • Department of Trauma, Hand and Reconstructive Surgery, University Hospital Giessen, Germany.
  • Max-Planck-Institute for Heart- and Lung Research, CPI - DNA & RNA Technologies, DZHK - Advanced Molecular Analytics Platform RheinMain, Bad Nauheim, Germany.
  • Department of Orthopaedics and Orthopaedic Surgery, University Hospital Giessen and Marburg, Giessen, Germany.
  • Experimental Trauma Surgery, Justus Liebig University Giessen, Giessen, Germany.

Förderung

  • Pickenpack Foundation
  • Kerckhoff-Foundation
  • BMBF Bonn

Zitieren

APA

Heck, C., Zimmermann-Geller, B., Haun, S., Lötfering, F., Welbrink, P., Kürsammer, D., Frommer, K. W., Arnold-Gräf, M., Korb-Pap, A., Knothe, A., Schulz, N., Simianer, S., Tarner, I., Hermann, W., Biehl, C., Günther, S., Steinmeyer, J., Lips, K. S., Rickert, M., …, & Neumann, E. (2025). Influence of canstatin on fibroblast-driven hypervascularisation in rheumatoid arthritis. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.05.019

Vancouver

Heck C, Zimmermann-Geller B, Haun S, Lötfering F, Welbrink P, Kürsammer D, et al. Influence of canstatin on fibroblast-driven hypervascularisation in rheumatoid arthritis. Annals of the Rheumatic Diseases. 2025. doi:10.1016/j.ard.2025.05.019

BibTeX
@article{Heck2025,
  author = {Heck, Corinna and Zimmermann-Geller, Birgit and Haun, Sophie and Lötfering, Frederik and Welbrink, Paula and Kürsammer, Daria and Frommer, Klaus W and Arnold-Gräf, Mona and Korb-Pap, Adelheid and Knothe, Anna and Schulz, Nils and Simianer, Stefan and Tarner, Ingo and Hermann, Walter and Biehl, Christoph and Günther, Stefan and Steinmeyer, Jürgen and Lips, Katrin S and Rickert, Markus and Rehart, Stefan and Müller-Ladner, Ulf and Neumann, Elena},
  title = {Influence of canstatin on fibroblast-driven hypervascularisation in rheumatoid arthritis},
  journal = {Annals of the Rheumatic Diseases},
  year = {2025},
  doi = {10.1016/j.ard.2025.05.019}
}
Kostenlos starten →